<List><item><source>MED</source><extId>26583803</extId><pmcid>PMC4742391</pmcid><annotations><annotation><prefix>ts with either CNS (</prefix><exact>NCT02031965</exact><postfix>) or non-CNS (NCT009</postfix><tags><tag><name>NCT02031965</name><uri>http://identifiers.org/clinicaltrials/NCT02031965</uri></tag></tags><id>http://europepmc.org/articles/PMC4742391#europepmc-286e8de54b78bf2fb50d09fc37af332f</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>031965) or non-CNS (</prefix><exact>NCT00931931</exact><postfix>) solid tumors, the </postfix><tags><tag><name>NCT00931931</name><uri>http://identifiers.org/clinicaltrials/NCT00931931</uri></tag></tags><id>http://europepmc.org/articles/PMC4742391#europepmc-06ac8d16e8a289ac86167b67058c685a</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>